Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.86
-0.01 (-0.17%)
At close: Apr 24, 2026, 4:00 PM EDT
5.87
+0.01 (0.17%)
After-hours: Apr 24, 2026, 6:11 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $190.95 million as of April 24, 2026. Its market cap has increased by 161.27% in one year.
Market Cap
190.95M
Enterprise Value
77.90M
1-Year Change
161.27%
Ranking
Category
Stock Price
$5.86
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $190.95M, a decrease of -46.18%. That is a compound annual growth rate of -19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 190.95M | -0.82% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 202.76M |
| Replimune Group | 199.83M |
| Karyopharm Therapeutics | 195.23M |
| Canton Strategic Holdings | 193.20M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Acumen Pharmaceuticals | 185.59M |
| Unicycive Therapeutics | 183.98M |